M. Kavallaris et al., MDR1 AND MULTIDRUG RESISTANCE-ASSOCIATED PROTEIN (MRP) GENE-EXPRESSION IN EPITHELIAL OVARIAN-TUMORS, Cancer letters, 102(1-2), 1996, pp. 7-16
Clinical drug resistance poses a major problem in the successful treat
ment of ovarian cancer. Two genes, MDR1 and MRP, have been found to pl
ay a role in the multidrug resistance phenotype of a number of human t
umors. Using a sensitive semiquantitative PCR assay we examined 53 pri
mary untreated ovarian tumors for expression of both MDR1 and MRP gene
s. Approximately one-third of the tumors expressed MDR1 while all the
tumors expressed varying levels of the MRP gene.